Sarepta Therapeutics, Inc. (SRPT) Net margin 2016–2025
Sarepta Therapeutics, Inc. (SRPT) net profit margin by fiscal year — reported net income divided by reported revenue.
-38.3%FY2025 · since FY2016: -4930.2% → -38.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -38.3% | -51.4 pp |
| FY2024 | 13.2% | +60.0 pp |
| FY2023 | -46.8% | +36.6 pp |
| FY2022 | -83.4% | -15.0 pp |
| FY2021 | -68.4% | +53.2 pp |
| FY2020 | -121.6% | +66.2 pp |
| FY2019 | -187.8% | -67.5 pp |
| FY2018 | -120.2% | -87.4 pp |
| FY2017 | -32.8% | +4897.4 pp |
| FY2016 | -4930.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice